Horsham, UK. (PRWEB UK) 4 September 2013
This new alliance will trade exclusively as Spectrum. The aim is to provide a comprehensive range of offerings which will help to ensure the continued growth of the operation under the leadership of Managing Director Dr Angela Gisby. “We are extremely pleased to join forces with Quantum and remain at the leading edge of clinical, regulatory and pharmacovigilance consulting and medical writing services. Clients of both Spectrum and Quantum can look forward to the benefits of this union in terms of overall service offering, expanded capabilities and added value” said Dr Gisby.
The deal creates a formidable new force in this highly specialised sector of pharmaceutical support services, by leveraging Spectrum’s broad portfolio of clients and Quantum’s solid reputation in complimentary service offerings.
Spectrum Regulatory Solutions was established in 2005 and provides a full-service consultancy to the healthcare industry. Uniquely, this comprises a suite of services which support manufacturers both during the run-up to obtaining marketing approval, and in post-marketing activities. These services include regulatory affairs, medical writing, safety and vigilance, market access, readability, quality assurance and compliance. Spectrum’s experience covers both medicinal products – pharmaceutical, biological, OTC, cosmetics, herbal and nutritional – and medical devices.
Spectrum has gained a reputation for quality, reliability and responsiveness. To preserve this reputation and prepare for future success, Spectrum recently successfully obtained ISO 9001:2008 certification, the highest standard of business quality management.
Spectrum is part of the Zaicom International group of companies, established in 1998, which also includes Zaicom Healthcare, Zaicom Research Plus and Zaicom Consulting. “This acquisition is exciting news for the whole group as it heralds Zaicom’s first move in an ambitious expansion plan in which it aims to become a £multi-million a year group by 2017. The addition of the Quantum business can only benefit our global business further, giving us more penetration in this key sector” added Zaicom International group CEO, Graeme Chrystal.
Quantum Medical has been an industry-leading provider of clinical, regulatory and pharmacovigilance services including medical writing, training, consultancy and project management for 15 years. “Quantum has been working alongside a small number of large global pharmaceutical, consumer health and animal health organisations. We now look forward to playing our part in the growth of Spectrum, and of the wider Zaicom International group, by having access to a much broader portfolio of clients” said Alan Nicolle, Managing Director, Quantum.
Quantum was part of the Interlace Global Group which is now comprised of three industry-leading medical communications companies supporting global pharmaceutical companies – Wells Healthcare (WHC), Interlace Communications and WHC Inc operating in the USA.
Owner and Group Managing Director of Interlace Global Group Mark Forbes Irving said “Following a strategic review of our global business we’ve made the decision to focus our activities where we see most growth and opportunity, specifically in the fast developing eMedia field with our unique digital training and interactive e-learning strengths that provide new opportunities for our clients. This will provide an offering that complements our traditional areas of strength – strategic consultancy, publication and communication planning, writing, advocacy development, live events, strategic advisory boards, creative services, clinical trial support and bespoke market access programmes. This divestment and creation of the Quantum and Spectrum combined business therefore makes a lot of sense for us right now”.
Ellie Coutts – Marketing Executive
+44 (0)1403 320220
Google+: Spectrum Regulatory Solutions